NZ587906A - Treatment for ocular-related disorders - Google Patents
Treatment for ocular-related disordersInfo
- Publication number
- NZ587906A NZ587906A NZ587906A NZ58790609A NZ587906A NZ 587906 A NZ587906 A NZ 587906A NZ 587906 A NZ587906 A NZ 587906A NZ 58790609 A NZ58790609 A NZ 58790609A NZ 587906 A NZ587906 A NZ 587906A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ocular
- compound
- compounds
- use according
- disorder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3507308P | 2008-03-10 | 2008-03-10 | |
| PCT/US2009/036119 WO2009114373A1 (en) | 2008-03-10 | 2009-03-05 | Treatment for ocular-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ587906A true NZ587906A (en) | 2011-12-22 |
Family
ID=40583469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ587906A NZ587906A (en) | 2008-03-10 | 2009-03-05 | Treatment for ocular-related disorders |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP2285378A1 (ko) |
| JP (1) | JP2011513488A (ko) |
| KR (1) | KR20110009084A (ko) |
| CN (1) | CN101965188A (ko) |
| AR (1) | AR070975A1 (ko) |
| AU (1) | AU2009223501A1 (ko) |
| BR (1) | BRPI0909659A2 (ko) |
| CA (1) | CA2717991A1 (ko) |
| CL (1) | CL2009000551A1 (ko) |
| CO (1) | CO6290691A2 (ko) |
| CR (1) | CR11644A (ko) |
| DO (1) | DOP2010000266A (ko) |
| IL (1) | IL207906A0 (ko) |
| MA (1) | MA32211B1 (ko) |
| MX (1) | MX2010008308A (ko) |
| NI (1) | NI201000131A (ko) |
| NZ (1) | NZ587906A (ko) |
| RU (1) | RU2010141560A (ko) |
| SV (1) | SV2010003658A (ko) |
| TW (1) | TW200950784A (ko) |
| WO (1) | WO2009114373A1 (ko) |
| ZA (1) | ZA201005337B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201034675A (en) | 2008-12-18 | 2010-10-01 | Sanofi Aventis | Method for treating macular degeneration |
| EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ301750B6 (cs) * | 1999-12-24 | 2010-06-09 | Aventis Pharma Limited | Bicyklický pyrrolový derivát, jeho použití pri výrobe léciva, farmaceutická kompozice tento derivát obsahující a pro použití pri lécení |
| CA2400923A1 (en) * | 2000-02-25 | 2001-08-30 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| KR20140025610A (ko) * | 2005-09-30 | 2014-03-04 | 미카나 테라퓨틱스, 인크. | 치환된 피라졸 화합물 |
| CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Application Discontinuation
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en active Application Filing
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010141560A (ru) | 2012-04-20 |
| CL2009000551A1 (es) | 2009-08-21 |
| CN101965188A (zh) | 2011-02-02 |
| MX2010008308A (es) | 2010-08-11 |
| SV2010003658A (es) | 2011-01-31 |
| AR070975A1 (es) | 2010-05-19 |
| CA2717991A1 (en) | 2009-09-17 |
| ZA201005337B (en) | 2011-04-28 |
| MA32211B1 (fr) | 2011-04-01 |
| WO2009114373A1 (en) | 2009-09-17 |
| IL207906A0 (en) | 2010-12-30 |
| AU2009223501A1 (en) | 2009-09-17 |
| CR11644A (es) | 2010-11-22 |
| NI201000131A (es) | 2011-09-29 |
| JP2011513488A (ja) | 2011-04-28 |
| KR20110009084A (ko) | 2011-01-27 |
| DOP2010000266A (es) | 2010-09-30 |
| TW200950784A (en) | 2009-12-16 |
| BRPI0909659A2 (pt) | 2015-09-22 |
| CO6290691A2 (es) | 2011-06-20 |
| EP2285378A1 (en) | 2011-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6608309B2 (ja) | Ｃｍｔ及び関連疾患の処置のための新規な治療的アプローチ | |
| JP5875191B2 (ja) | Ｃｍｔ及び関連障害を処置するための新たな組成物 | |
| KR101663998B1 (ko) | 샤르코-마리-투스 질환 및 관련 장애를 치료하기 위한 필로카핀 및 메티마졸 조합 | |
| US20150231136A1 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
| Zhang et al. | Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex | |
| US20210401776A1 (en) | Method of treating refractory epilepsy syndromes using fenfluramine enantiomers | |
| JPH10236978A (ja) | 中枢カンナビノイドレセプターｃｂ１の既知の作用薬の利用 | |
| JP5919597B2 (ja) | デオキシコール酸およびその塩類の製剤 | |
| EP2852383A2 (en) | Methods for drug screen using zebrafish model and the compounds screened thereform | |
| KR20180121983A (ko) | Rxr 작용제 및 갑상선 호르몬의 조합을 사용한 근육 질환의 치료 | |
| AU2008251742A1 (en) | Inhibitors of acetyl-CoA carboxylase for treatment of neuronal hypometabolism | |
| US20220226270A1 (en) | Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use | |
| JP2000514402A (ja) | Ｖｅｇｆに関連する目の病気に関する治療処置 | |
| TW201605443A (zh) | 治療ｘ染色體脆折症及相關病症的方法 | |
| KR20210081338A (ko) | Iv형 콜라겐 질환의 치료를 위한 비페닐 설폰아미드 화합물 | |
| NZ587906A (en) | Treatment for ocular-related disorders | |
| US20110112101A1 (en) | Treatment for ocular-related disorders | |
| Sharif et al. | Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction | |
| CN101293831B (zh) | 3-羟基脂肪酸及其衍生物在制备钙离子通道调节剂中的用途 | |
| JP6522641B2 (ja) | 機械的な神経損傷を処置するための新規組成物 | |
| US8133861B2 (en) | Systemic purine administration: modulating axonal outgrowth of central nervous system neurons | |
| WO2024089691A1 (en) | Modulators and uses thereof | |
| Farmer et al. | Spontaneous and evoked angiotensin II sniffer cell activity in the lamina terminalis in vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |